tiprankstipranks
Trending News
More News >
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
US Market

ACADIA Pharmaceuticals (ACAD) Income Statement

Compare
2,418 Followers

ACADIA Pharmaceuticals Income Statement

Last quarter (Q3 2025), ACADIA Pharmaceuticals's total revenue was $278.63M, an increase of 11.27% from the same quarter last year. In Q3, ACADIA Pharmaceuticals's net income was $71.78M. See ACADIA Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 957.80M$ 726.44M$ 517.24M$ 484.14M$ 441.75M
Gross Profit
$ 875.96M$ 680.71M$ 507.07M$ 465.00M$ 421.20M
Operating Expenses
$ 645.16M$ 754.09M$ 730.66M$ 635.44M$ 707.79M
Depreciation and Amortization
$ 15.88M$ 5.55M$ 2.03M$ 3.34M$ 2.93M
EBITDA
$ 100.16M$ -67.83M$ -221.57M$ -167.09M$ -283.65M
Operating Income
$ 230.79M$ -73.38M$ -223.60M$ -170.44M$ -286.59M
Other Income/Expenses
$ 27.28M$ 22.34M$ 10.15M$ 2.92M$ 5.61M
Pretax Income
$ 258.07M$ -51.04M$ -213.44M$ -167.52M$ -280.97M
Net Income
$ 226.45M$ -61.29M$ -215.97M$ -167.87M$ -281.58M
Per Share Metrics
Basic EPS
$ 1.37$ -0.37$ -1.34$ -1.05$ -1.79
Diluted EPS
$ 1.36$ -0.37$ -1.34$ -1.05$ -1.79
Weighted Average Shares Outstanding
165.72M 163.82M 161.68M 160.49M 157.33M
Weighted Average Shares Outstanding (Diluted)
166.36M 163.82M 161.68M 160.49M 157.33M
Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History